Development of Antipsychotic Medications with Novel Mechanisms of Action Based on Computational Modeling of Hippocampal Neuropathology

Open Access

Peer-reviewed

Research Article

Peter J. Siekmeier ,

* E-mail: psiekmeier@mclean.harvard.edu

Affiliations Laboratory for Computational Neuroscience, McLean Hospital, Belmont, Massachusetts, United States of America, Harvard Medical School, Boston, Massachusetts, United States of America
⨯
David P. vanMaanen

Affiliations Laboratory for Computational Neuroscience, McLean Hospital, Belmont, Massachusetts, United States of America, Harvard Medical School, Boston, Massachusetts, United States of America
⨯

Reader Comments (0)

Schizophrenia
Is the Subject Area "Schizophrenia" applicable to this article?

Thanks for your feedback.
Hippocampus
Is the Subject Area "Hippocampus" applicable to this article?

Thanks for your feedback.
Electroencephalography
Is the Subject Area "Electroencephalography" applicable to this article?

Thanks for your feedback.
Behavior
Is the Subject Area "Behavior" applicable to this article?

Thanks for your feedback.
Gamma-aminobutyric acid
Is the Subject Area "Gamma-aminobutyric acid" applicable to this article?

Thanks for your feedback.
Antipsychotics
Is the Subject Area "Antipsychotics" applicable to this article?

Thanks for your feedback.
Pyramidal cells
Is the Subject Area "Pyramidal cells" applicable to this article?

Thanks for your feedback.
Interneurons
Is the Subject Area "Interneurons" applicable to this article?

Thanks for your feedback.